2026
article
OpenAlex
Hao-Shen Cheng, Irini Yacoub, Winston Wong, Lara A. Dunn et autres
ABSTRACT This retrospective study compared the efficacy and toxicity of concurrent triweekly versus weekly cisplatin in patients with previously untreated, biopsy‐proven NPC who received definitive CRT followed by adjuvant chemotherapy. Patients with distant metastasis, Karnofsky Performance Status < 80, induction chemotherapy, or …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Colette Shen, Yara Abdou, Linda Chen, Mina Lobbous et autres
Abstract Purpose Outcomes for patients with HER2-negative breast cancer with brain metastases remain poor. Therapeutic strategies that enhance radiation-induced DNA damage and anti-tumor immune response may improve intracranial control. We evaluated toxicity and intracranial disease control in patients receiving combination stereotactic radiosurgery …
us, in
(code pays fourni par la source)
2026
article
OpenAlex
Lianping Xu, Shasha Wu, Sandra Rose, Linda Chen et autres
cn, us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Da Sol Kim, Linda Chen, Timothy Reynolds, Paul Godley
us
(code pays fourni par la source)
2026
article
OpenAlex
Michael R. McGovern, Timothy Reynolds, Linda Chen, Da Sol Kim et autres
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Beverly Fuerte, Da Sol Kim, Kenneth Youens, Timothy Reynolds et autres
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Christopher Andrew Barker, Ryan Michael Lanning, Shlomo A. Koyfman, Jay Justin Liao et autres
9506 Background: Locally advanced (T3-4/N+/M0) and unresectable cutaneous squamous cell carcinoma (LAUCSCC) patients (pts) have been historically treated with definitive radiotherapy (RT) +/- chemotherapy, yielding poor outcomes (18m progression-free survival [PFS] rates of ~38%). More recently, anti-PD1 immunotherapy with cemiplimab (cemi) led …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Erica Zeng, Linda Chen, Eva Feredoes, John Shahki et autres
ca, gb
(code pays fourni par la source)
2026
article
OpenAlex
Erica Qureshi, Quynh Doan, Linda Chen, Garth D. Meckler et autres
ca
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Fan Yang, Edward Christopher Dee, Annu Singh, Yingzhi Wu et autres
Importance: Osteoradionecrosis (ORN) is a potentially debilitating late complication of radiotherapy (RT) for head and neck cancer. While proton therapy offers superior dose conformality, its impact on ORN risk remains uncertain, particularly in patients with oropharyngeal squamous cell carcinoma (OPSCC). Objective: To …
us, th, ca
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Tim Reynolds, William Ye, Linda Chen, Mohammad Reza Eskandari et autres
Abstract Introduction: CLL/SLL is the most common leukemia in adults in the United States, with ~21,000 cases diagnosed annually. National Comprehensive Cancer Network (NCCN) guidelines recommend testing for certain prognostic variables prior to initiation of CLL/SLL treatment (tx). For patients (pts) with …
pt, us, py
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Irini Ihab Yacoub, Achraf A. Shamseddine, Daniel Kallini, Nader Mohamed et autres
Purpose/Objectives: Adenoid cystic carcinoma (ACC) of the head and neck is a rare malignancy with a prolonged but infiltrative course, marked by perineural invasion and high risk of local recurrence and distant metastases. The standard of care for head/neck ACC is surgery …
us
(code pays fourni par la source)